QQ客服 官方微博 反馈留言

	Tumor growth velocity: A modified tumor growth rate defining tumor progression during sorafenib treatment in patients with metastatic renal cell carcinoma
	Wang, Hong-Kai; Xu, Wen-Hao; Ma, Chun-Guang; Zhou, Liang-Ping; Shi, Guo-Hai; Zhang, Hai-Liang; Ye, Ding-Wei
刊名	INTERNATIONAL JOURNAL OF UROLOGY
	2019
卷号	26期号:1
关键词	clinical trials renal cell carcinoma sorafenib targeted therapy tumor growth rate
ISSN号	0919-8172
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3596193
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Wang, Hong-Kai,Xu, Wen-Hao,Ma, Chun-Guang,et al. Tumor growth velocity: A modified tumor growth rate defining tumor progression during sorafenib treatment in patients with metastatic renal cell carcinoma[J]. INTERNATIONAL JOURNAL OF UROLOGY,2019,26(1).
APA	Wang, Hong-Kai.,Xu, Wen-Hao.,Ma, Chun-Guang.,Zhou, Liang-Ping.,Shi, Guo-Hai.,...&Ye, Ding-Wei.(2019).Tumor growth velocity: A modified tumor growth rate defining tumor progression during sorafenib treatment in patients with metastatic renal cell carcinoma.INTERNATIONAL JOURNAL OF UROLOGY,26(1).
MLA	Wang, Hong-Kai,et al."Tumor growth velocity: A modified tumor growth rate defining tumor progression during sorafenib treatment in patients with metastatic renal cell carcinoma".INTERNATIONAL JOURNAL OF UROLOGY 26.1(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。